104 related articles for article (PubMed ID: 6508318)
1. [Discovery and development of unknown potentialities of microorganisms with special reference to saframycin group antitumor antibiotics].
Arai T
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2617-24. PubMed ID: 6508318
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of new semisynthetic saframycin derivatives.
Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T
Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920
[TBL] [Abstract][Full Text] [Related]
3. Directed biosynthesis of new saframycin derivatives with resting cells of Streptomyces lavendulae.
Arai T; Yazawa K; Takahashi K; Maeda A; Mikami Y
Antimicrob Agents Chemother; 1985 Jul; 28(1):5-11. PubMed ID: 3839995
[TBL] [Abstract][Full Text] [Related]
4. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C.
Arai T; Takahashi K; Ishiguro K; Mikami Y
Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of saframycins.
Kishi K; Yazawa K; Takahashi K; Mikami Y; Arai T
J Antibiot (Tokyo); 1984 Aug; 37(8):847-52. PubMed ID: 6480503
[TBL] [Abstract][Full Text] [Related]
6. Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae.
Mikami Y; Takahashi K; Yazawa K; Arai T; Namikoshi M; Iwasaki S; Okuda S
J Biol Chem; 1985 Jan; 260(1):344-8. PubMed ID: 3880741
[TBL] [Abstract][Full Text] [Related]
7. Increased production of saframycin A and isolation of saframycin S.
Arai T; Takahashi K; Ishiguro K; Yazawa K
J Antibiot (Tokyo); 1980 Sep; 33(9):951-60. PubMed ID: 7440416
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of saframycin antitumor antibiotics: sequence selectivities in the covalent binding of saframycins A and S to deoxyribonucleic acid.
Rao KE; Lown JW
Chem Res Toxicol; 1990; 3(3):262-7. PubMed ID: 2131839
[TBL] [Abstract][Full Text] [Related]
9. Isolation and structural elucidation of new saframycins Y3, Yd-1, Yd-2, Ad-1, Y2b and Y2b-d.
Yazawa K; Takahashi K; Mikami Y; Arai T; Saito N; Kubo A
J Antibiot (Tokyo); 1986 Dec; 39(12):1639-50. PubMed ID: 3818437
[TBL] [Abstract][Full Text] [Related]
10. Saframycin S, a new saframycin group antibiotic.
Mikami Y; Yokoyama K; Tabeta H; Nakagaki K; Arai T
J Pharmacobiodyn; 1981 Apr; 4(4):282-6. PubMed ID: 7264873
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of satellite antibiotics, mimosamycin and chlorocarcins from Streptomyces lavendulae, streptothricin source.
Arai T; Yazawa K; Mikami Y
J Antibiot (Tokyo); 1976 Apr; 29(4):398-407. PubMed ID: 931809
[TBL] [Abstract][Full Text] [Related]
12. Binding of saframycin A, a heterocyclic quinone anti-tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide.
Ishiguro K; Takahashi K; Yazawa K; Sakiyama S; Arai T
J Biol Chem; 1981 Mar; 256(5):2162-7. PubMed ID: 7193208
[TBL] [Abstract][Full Text] [Related]
13. Structure and conformation of saframycin R determined by high field 1H and 13C NMR and its interactions with DNA in solution.
Lown JW; Hanstock CC; Joshua AV; Arai T; Takahashi K
J Antibiot (Tokyo); 1983 Sep; 36(9):1184-94. PubMed ID: 6630077
[TBL] [Abstract][Full Text] [Related]
14. Studies on water-soluble antitumor antibiotics produced by Streptomyces sp., No. OS-786.
Iwai Y; Komiyama K; Oiwa R; Awaya J; Umezawa I
Kitasato Arch Exp Med; 1971 Jun; 44(2):95-105. PubMed ID: 5148026
[No Abstract] [Full Text] [Related]
15. Synthesis of saframycins. X. Transformation of (-)-saframycin A to (-)-saframycin Mx type compound with the structure proposed for saframycin E.
Saito N; Harada S; Nishida M; Inouye I; Kubo A
Chem Pharm Bull (Tokyo); 1995 May; 43(5):777-82. PubMed ID: 7553964
[TBL] [Abstract][Full Text] [Related]
16. Identification of GAPDH as a protein target of the saframycin antiproliferative agents.
Xing C; LaPorte JR; Barbay JK; Myers AG
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5862-6. PubMed ID: 15079082
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of binding and single-strand scission of deoxyribonucleic acid by the antitumor antibiotics saframycins A and C.
Lown JW; Joshua AV; Lee JS
Biochemistry; 1982 Feb; 21(3):419-28. PubMed ID: 7066293
[TBL] [Abstract][Full Text] [Related]
18. Identification of producer and biological activities of new antibiotics, mimosamycin and chlorocarcins.
Mikami Y; Yokoyama K; Omi A; Arai T
J Antibiot (Tokyo); 1976 Apr; 29(4):408-14. PubMed ID: 931810
[TBL] [Abstract][Full Text] [Related]
19. Structural studies on minor components of saframycin group antibiotics saframycins F, G and H.
Mikami Y; Takahashi K; Yazawa K; Hour-Young C; Arai T; Saito N; Kubo A
J Antibiot (Tokyo); 1988 Jun; 41(6):734-40. PubMed ID: 3403367
[TBL] [Abstract][Full Text] [Related]
20. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
